Pharmacists seek clarity on banned cough syrup stock

Pharmacists are seeking clarification from the DCGI regarding the handling of recently banned cough syrups for children under four, specifically concerning existing stocks and prescriptions. The IPA has requested guidance on whether to return stocks or sell them until depleted, and if prescriptions for young children can be dispensed. The industry is also seeking more time for the transition.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/5CjhmNJ
via IFTTT